echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Small group purchases, poor countries need to pay more for new crown vaccines: unfortunately

    Small group purchases, poor countries need to pay more for new crown vaccines: unfortunately

    • Last Update: 2021-02-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On 4 February local time, the WHO Regional Office for Africa held an online press conference in Brazzaville, the capital of the Congo (Bu) to present the first phase of vaccination arrangements for the New Coronary Pneumonia Vaccine Implementation Programme (COVAX) in Africa.
    under the first phase of the vaccine distribution programme, 90 million doses of the vaccine will arrive on the continent starting in February, and African Governments have been notified of the specific distribution of doses.
    be the largest vaccination campaign in the continent's history.
    WHO Regional Director for Africa, Morty, noted that many developed countries are already getting new crown vaccines on a large scale, while African countries have been waiting for the vaccine to arrive, and some African countries even need to pay higher purchase prices than others to get the vaccine.
    countries that buy large doses of vaccines can usually talk about lower prices, and we acknowledge that this is the reality of the global market at the moment," she said.
    poor countries (because of relatively small purchases) often buy vaccines at higher prices than high-income countries.
    we are also working to better manage the ordering process.
    's new coronary pneumonia vaccine implementation plan and the action being taken by the AU are also pushing for national vaccine procurement, which is also a way to push for global pricing.
    , according to Morty, 90 million doses of the vaccine in the first phase of the New Coronary Pneumonia Vaccine Implementation Plan will be used to support African countries in vaccinating about 3 percent of the population in the first half of this year, including health workers and vulnerable groups.
    With the increase in the capacity of the new crown vaccine and the increase in the number of candidate vaccines, the New Crown Pneumonia Vaccine Implementation Plan is expected to provide a cumulative 600 million doses of the vaccine to African countries by the end of this year, covering about 20% of the population.
    White House spokesman: The United States will first ensure that Americans complete the new crown vaccination at a White House press conference on February 4, local time, a reporter asked White House press secretary Jen Psaki, the U.S. government's plan on vaccine distribution, Jane Psaki said the U.S. priority is to ensure that the American people complete the new crown vaccination as far as possible.
    : "We have re-joined the World Health Organization to give the United States a place at the global negotiating table to play a constructive role in providing Americans with access to safe and effective vaccines," Jane Psaki added in a brief response.
    " CCTV News Client Source: CCTV News Client Copyright Notice: All text, pictures and audio and video materials that indicate "Source: Mets Medicine" or "Source: MedSci Originals" on this website belong to Mets Medical, which is not authorized, and no media, website or individual may reproduce them, and the authorizing their reprints must indicate "Source: Mets Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    at the same time reproduced content does not represent the position of this site.
    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.